| |
| |
|
| Insider
Information: |
Clement Christopher G |
| Relationship: |
Chief Executive Office... |
| City: |
East Brunswick |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
276,511 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
276,511 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Savient Pharmaceuticals Inc |
SVNTQ |
Former President & CEO |
2009-12-09 |
276,511 |
2004-06-01 |
0 |
Premium* |
|
|
Point Therapeutics Inc |
POTP |
Chief Executive Office... |
2015-12-04 |
0 |
2012-01-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| POTP |
Point Therapeutics Inc |
Chief Executive Officer |
• • – |
2015-12-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(54,558) |
0 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & COO |
• – – |
2003-02-01 |
5 |
A |
$2.13 |
$2,774 |
D/D |
1,300 |
1,903 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & COO |
• – – |
2003-05-01 |
5 |
A |
$2.13 |
$1,666 |
D/D |
781 |
2,684 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & COO |
• – – |
2003-08-01 |
5 |
A |
$2.13 |
$1,664 |
D/D |
780 |
3,464 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & COO |
• – – |
2003-11-01 |
5 |
A |
$2.13 |
$1,666 |
D/D |
781 |
4,245 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & COO |
• – – |
2004-06-01 |
4 |
A |
$2.39 |
$38,256 |
D/D |
16,000 |
23,103 |
|
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2005-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
68,350 |
91,453 |
|
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2005-05-18 |
4 |
B |
$3.08 |
$46,368 |
D/D |
15,000 |
106,453 |
2.74 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2006-04-12 |
4 |
AS |
$5.87 |
$60,537 |
D/D |
(10,313) |
146,140 |
|
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2006-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
156,453 |
|
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2007-02-15 |
4 |
AS |
$14.49 |
$110,447 |
D/D |
(7,624) |
203,516 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2006-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
211,140 |
0 |
- |
|
| POTP |
Point Therapeutics Inc |
Chief Operating Officer |
• • – |
2012-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
215,661 |
215,661 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2008-02-15 |
4 |
AS |
$20.00 |
$222,240 |
D/D |
(11,112) |
240,457 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2008-04-14 |
4 |
AS |
$19.06 |
$144,304 |
D/D |
(7,570) |
246,532 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2007-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
44,121 |
247,637 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2008-01-08 |
4 |
S |
$23.09 |
$119,765 |
D/D |
(5,170) |
251,399 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2008-01-09 |
4 |
S |
$21.88 |
$109,411 |
D/D |
(5,000) |
251,399 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2008-01-10 |
4 |
S |
$22.42 |
$112,101 |
D/D |
(5,000) |
251,399 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2008-01-11 |
4 |
S |
$22.00 |
$109,997 |
D/D |
(5,000) |
251,399 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2008-01-14 |
4 |
S |
$21.64 |
$108,200 |
D/D |
(5,000) |
251,399 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2008-01-08 |
4/A |
S |
$23.09 |
$115,818 |
D/D |
(5,000) |
251,569 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2008-01-09 |
4/A |
S |
$21.88 |
$109,411 |
D/D |
(5,000) |
251,569 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2008-01-15 |
4 |
S |
$21.35 |
$106,789 |
D/D |
(5,000) |
251,569 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President & CEO |
• – – |
2008-01-16 |
4 |
S |
$21.24 |
$106,200 |
D/D |
(5,000) |
251,569 |
0 |
- |
|
52 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
